Xiaoping Chen

17PUBLICATIONS
30CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMolecular targetsPredictive and prognostic markersCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jun 30, 2026
Advances and prospects in cell therapy for cancer: explorations from T cells to stem cells.

|Mar 17, 2026
The multifaceted roles of the ACSL family in cancer: Metabolic reprogramming, ferroptosis regulation and tumour immune microenvironment remodelling.

Haocai Li, Weijian Wang, Juncheng Zhan

|Oct 10, 2025
VRK2 targeting potentiates anti-PD-1 immunotherapy in hepatocellular carcinoma through MYC destabilization.

Chen Su, Zhibin Liao, Jie Mo

|Apr 26, 2025
m6A-Mediated TMCO3 Promotes Hepatocellular Carcinoma Progression by Facilitating the Membrane Translocation and Activation of AKT.

Xinxin Li, Mengzhen Han, He Zhu

|Jun 25, 2024
Disrupting CCDC137-mediated LZTS2 and β-TrCP interaction in the nucleus inhibits hepatocellular carcinoma development via β-catenin and AKT.

Lei Xu, Qiumeng Liu, Hailing Liu

|Feb 08, 2024
SOX on tumors, a comfort or a constraint?

Junqing Jiang, Yufei Wang, Mengyu Sun

Pageof 3

Frequent Collaborators

4 joint publications

Bixiang Zhang

4 joint publications

Bixiang Zhang

3 joint publications

Wenjie Huang

3 joint publications

Limin Xia